NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,581 Cr | ₹6,887 Cr | ₹5,657 Cr | ₹5,109 Cr | ₹4,792 Cr |
What is the latest Total Liabilities ratio of NATCO PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹8,581 Cr |
| Mar2024 | ₹6,887 Cr |
| Mar2023 | ₹5,657 Cr |
| Mar2022 | ₹5,109 Cr |
| Mar2021 | ₹4,792 Cr |
How is Total Liabilities of NATCO PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,581 Cr | 24.59 | |
| Mar2024 | ₹6,887 Cr | 21.73 | |
| Mar2023 | ₹5,657 Cr | 10.73 | |
| Mar2022 | ₹5,109 Cr | 6.62 | |
| Mar2021 | ₹4,792 Cr | - | |
Compare Total Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,723.8 Cr | -2.7% | -7.8% | -36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2.7% |
-7.8% |
-36.3% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses